Works matching Adenovirus vaccine


Results: 947
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Safety and Immunogenicity of a Recombinant Adenovirus Type-5–Vectored Coronavirus Disease 2019 (COVID-19) Vaccine With a Homologous Prime-Boost Regimen in Healthy Participants Aged ≥6 Years: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Trial

    Published in:
    Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e783, doi. 10.1093/cid/ciab845
    By:
    • Zhu, Fengcai;
    • Jin, Pengfei;
    • Zhu, Tao;
    • Wang, Wenjuan;
    • Ye, Huayue;
    • Pan, Hongxing;
    • Hou, Lihua;
    • Li, Jingxin;
    • Wang, Xue;
    • Wu, Shipo;
    • Wang, Ying;
    • Gou, Jinbo;
    • Huang, Haitao;
    • Wu, Hongbin;
    • Wang, Xuewen;
    • Chen, Wei
    Publication type:
    Article
    19
    20
    21
    22

    A Bivalent Adenovirus-Vectored Vaccine Induces a Robust Humoral Response, but Does Not Protect Cynomolgus Macaques Against a Lethal Challenge With Sudan Virus.

    Published in:
    Journal of Infectious Diseases, 2024, v. 230, n. 5, p. 1083, doi. 10.1093/infdis/jiae056
    By:
    • Tol, Sarah van;
    • Fletcher, Paige;
    • Feldmann, Friederike;
    • Mukesh, Reshma K;
    • Port, Julia R;
    • Gallogly, Shane;
    • Schulz, Jonathan E;
    • Rhoderick, Joseph F;
    • Makinson, Rebecca;
    • Carmody, Aaron;
    • Myers, Lara;
    • Lovaglio, Jamie;
    • Smith, Brian J;
    • Okumura, Atsushi;
    • Shaia, Carl;
    • Saturday, Greg;
    • Marzi, Andrea;
    • Lambe, Teresa;
    • Munster, Vincent J;
    • Doremalen, Neeltje van
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29

    A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)‐Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 6, p. 479, doi. 10.1634/theoncologist.2019-0608
    By:
    • Gatti‐Mays, Margaret E.;
    • Redman, Jason M.;
    • Donahue, Renee N.;
    • Palena, Claudia;
    • Madan, Ravi A.;
    • Karzai, Fatima;
    • Bilusic, Marijo;
    • Sater, Houssein Abdul;
    • Marté, Jennifer L.;
    • Cordes, Lisa M.;
    • McMahon, Sheri;
    • Steinberg, Seth M.;
    • Orpia, Alanvin;
    • Burmeister, Andrea;
    • Schlom, Jeffrey;
    • Gulley, James L.;
    • Strauss, Julius
    Publication type:
    Article
    30
    31

    Intensity of Humoral Immune Responses, Adverse Reactions, and Post-Vaccination Morbidity after Adenovirus Vector-Based and mRNA Anti-COVID-19 Vaccines.

    Published in:
    Vaccines, 2022, v. 10, n. 8, p. 1268, doi. 10.3390/vaccines10081268
    By:
    • Voulgaridi, Ioanna;
    • Sarrou, Styliani;
    • Dadouli, Aikaterini;
    • Peristeri, Athanasia-Marina;
    • Nasika, Asimina;
    • Onoufriadis, Ilias;
    • Kyritsi, Maria A.;
    • Anagnostopoulos, Lemonia;
    • Theodoridou, Aikaterini;
    • Avakian, Ioanna;
    • Pappa, Dimitra;
    • Konstantinou, Adamos-Konstantinos;
    • Papadamou, Georgia;
    • Mouchtouri, Varvara A.;
    • Petinaki, Efi;
    • Speletas, Matthaios;
    • Hadjichristodoulou, Christos
    Publication type:
    Article
    32

    Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Prospective Cohort Study.

    Published in:
    Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060853
    By:
    • Assawasaksakul, Theerada;
    • Lertussavavivat, Tanat;
    • Sathitratanacheewin, Seelwan;
    • Oudomying, Nont;
    • Vichaiwattana, Preeyaporn;
    • Wanlapakorn, Nasamon;
    • Poovorawan, Yong;
    • Avihingsanon, Yingyos;
    • Assawasaksakul, Nawaporn;
    • Buranapraditkun, Supranee;
    • Kittanamongkolchai, Wonngarm
    Publication type:
    Article
    33
    34
    35

    Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes.

    Published in:
    PLoS ONE, 2025, v. 20, n. 2, p. 1, doi. 10.1371/journal.pone.0318098
    By:
    • Ganeshan, Harini;
    • Huang, Jun;
    • Belmonte, Maria;
    • Belmonte, Arnel;
    • Inoue, Sandra;
    • Velasco, Rachel;
    • Maiolatesi, Santina;
    • Limbach, Keith;
    • Patterson, Noelle;
    • Sklar, Marvin J.;
    • Soisson, Lorraine;
    • Epstein, Judith E.;
    • Edgel, Kimberly A.;
    • Peters, Bjoern;
    • Hollingdale, Michael R.;
    • Villasante, Eileen;
    • Duplessis, Christopher A.;
    • Sedegah, Martha
    Publication type:
    Article
    36
    37

    Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models.

    Published in:
    2018
    By:
    • Qiang Guo;
    • Shipo Wu;
    • Lihua Hou;
    • Changpeng Ren;
    • Mengsu Zhao;
    • Xiaohong Song;
    • Busen Wang;
    • Yanbo Wen;
    • Wei Chen;
    • Kin-Hang Kok;
    • Fuk-Woo Chan, Jasper;
    • Kwok-Yung Yuen;
    • Kwok-Man Poon, Vincent;
    • Chung-Sing Chan, Chris;
    • Chik-Yan Yip, Cyril;
    • Jian-Piao Cai;
    • Jinxia Zhang, Anna;
    • Kwok-Hung Chan;
    • Guo, Qiang;
    • Chan, Jasper Fuk-Woo
    Publication type:
    journal article
    38
    39

    A randomized trial comparing safety, immunogenicity and efficacy of self-amplifying mRNA and adenovirus-vector COVID-19 vaccines.

    Published in:
    NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-01017-5
    By:
    • Ho, Nhan Thi;
    • Hughes, Steve G.;
    • Sekulovich, Rose;
    • Ta, Van Thanh;
    • Nguyen, Thuong Vu;
    • Van Pham, Anh Thi;
    • Luong, Quang Chan;
    • Le Tran, Ly Thi;
    • Van Luu, Anh Thi;
    • Nguyen, Anh Ngoc;
    • Pham, Ha Thai;
    • Nguyen, Van Thu;
    • Berdieva, Dina;
    • Bugarini, Roberto;
    • Liu, Xuexuan;
    • Verhoeven, Carole;
    • Smolenov, Igor;
    • Nguyen, Xuan-Hung
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50